Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Softening up for a stink bid?

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Oct 30, 2020 10:51am

176 Views

Post# 31812700

RE:RE:Softening up for a stink bid?

Seems to me the same template for Phase 1 would have been used with simple write in for the allowance of the 2nd treatment.

It's really a slap in the face for the company and shareholders.

What if Covid had not caused the delay??

Jeez....

The company has accepted the blame and given the hospitial immunity from neglagance. And really the company had no choice if the wanted to the study to progress.

What a hachet job to come out of the gate with.

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage